RLF Peer Comparison

BSE: 512618

₹9.66

₹0.00 (0.00%)

As on 13-Nov-2026 11:50IST

Market cap

₹11 Cr

Revenue (TTM)

₹0 Cr

P/E Ratio

--

P/B Ratio

0.4

Div. Yield

0 %

Edit

	RLF	Sportking India	Silkflex Polymers (India)	Tejassvi Aaharam	Neochem Bio Solutions
Market cap (₹ Cr)	11	2,632	384	372	182
Revenue (₹ Cr)	0	2,767	110	67	111
Net Profit (₹ Cr)	-0.28	229.69	12.15	-1.05	12.03
Net Margin (%)	-27.41	8.31	10.97	-1.57	10.61
RoE (%)	-1.02	19.21	29.23	--	24.40
Price to Earnings	--	11.46	31.57	--	15.10
Price-To-Book	0.37	2.06	4.88	8.48	2.30

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	RLF	Sportking India	Silkflex Polymers (India)	Tejassvi Aaharam	Neochem Bio Solutions
Operating Revenue	1.08	2,524.23	80.16	17.92	84.17
Total Income	1.55	2,551.02	80.51	17.92	86.15
Total Expenditure	1.42	2,253.39	68.17	18.17	71.06
EBITDA	-0.34	270.84	11.98	-0.24	13.11
Depreciation	0.06	89.64	0.38	--	1.33
EBIT	-0.41	181.21	11.60	-0.24	11.79
Interest	0.07	54.30	2.56	0.49	3.51
Other Income	0.47	26.79	0.36	--	1.98
Exceptional Items	-0.05	--	--	--	--
Profit before Tax	-0.05	153.70	9.40	-0.73	10.26
Provision for Tax	0.18	40.55	2.40	--	2.51
Profit after Tax	-0.23	113.15	7.00	-0.73	7.75

Liabilities (₹ Cr)

	RLF	Sportking India	Silkflex Polymers (India)	Tejassvi Aaharam	Neochem Bio Solutions
Shareholder's Funds	27.61	1,006.91	35.61	-6.01	19.75
Minority Interest	--	--	--	--	--
Non-Current Liabilities	0.66	395.14	18.95	4.23	15.19
Current Liabilities	4.35	403.35	28.07	3.01	43.95
Total Liabilities	32.62	1,805.40	82.67	1.23	78.89

Assets (₹ Cr)

	RLF	Sportking India	Silkflex Polymers (India)	Tejassvi Aaharam	Neochem Bio Solutions
Non-Current Assets	29.51	790.83	18.75	--	25.81
Current Assets	3.11	1,014.56	63.88	1.23	53.08
Total Assets	32.62	1,805.40	82.67	1.23	78.89
Total Debt*	3.66	584.76	36.27	6.48	35.62
Net Current Assets	-1.24	611.21	35.81	-1.78	9.13
Contingent Liabilities	0.07	10.69	--	0.24	0.07

Cashflow (₹ Cr)

	RLF	Sportking India	Silkflex Polymers (India)	Tejassvi Aaharam	Neochem Bio Solutions
Cash From Operating Activities	0.46	414.62	-30.23	-0.67	2.59
Cash Flow from Investing Activities	-0.19	-66.71	-4.88	--	-1.69
Cash from Financing Activities	-0.26	-348.86	35.14	0.80	-1.20
Net Cash Inflow / Outflow	0.00	-0.95	0.03	0.13	-0.30

Ratios

Profitability Ratios

	RLF	Sportking India	Silkflex Polymers (India)	Tejassvi Aaharam	Neochem Bio Solutions
ROCE (%)	0.05	12.35	24.08	-123.61	27.34
ROE (%)	-0.82	11.85	29.24	0.00	48.82
ROA (%)	-0.70	5.98	11.58	-116.02	10.84
EBIT Margin (%)	11.50	11.79	15.40	-1.34	17.93
Net Margin (%)	-14.74	4.44	8.69	-4.05	9.00
Cash Profit Margin (%)	-15.48	8.03	9.21	-4.05	10.79

Growth Ratios

	RLF	Sportking India	Silkflex Polymers (India)	Tejassvi Aaharam	Neochem Bio Solutions
Revenue Growth (%)	-42.04	6.19	59.44	--	37.66
EBIT Growth (%)	-46.53	21.79	66.28	42.81	120.31
Net Profit Growth (%)	-611.66	60.84	78.17	13.20	330.28
EPS Growth (%)	-611.65	60.84	24.72	13.21	330.28
Book Value Growth (%)	-0.82	11.58	190.49	-13.75	64.58

Valuation Ratios

	RLF	Sportking India	Silkflex Polymers (India)	Tejassvi Aaharam	Neochem Bio Solutions
Price / Earnings	0.00	8.58	12.73	0.00	0.00
Price / Book Value	0.32	0.96	2.50	-3.56	0.00
Dividend Yield (%)	0.00	1.31	0.00	0.00	--
EV/EBITDA	99.50	5.22	10.16	-115.31	2.80
Market Cap (₹ Cr)	8.72	970.57	89.14	21.39	0.00

Solvency Ratios

	RLF	Sportking India	Silkflex Polymers (India)	Tejassvi Aaharam	Neochem Bio Solutions
Debt to Equity	0.13	0.58	1.02	-1.08	1.80
Short term debt to equity ratio	0.11	0.17	0.54	-0.37	1.01
Current Ratio	0.72	2.52	2.28	0.41	1.21
Quick Ratio	0.27	1.44	1.20	0.41	0.67
Interest Coverage	0.23	3.83	4.68	-0.50	3.93

Operating Efficiency Ratios

	RLF	Sportking India	Silkflex Polymers (India)	Tejassvi Aaharam	Neochem Bio Solutions
Debtors to sales (%)	59.14	18.08	12.64	3.88	30.03
Asset Turnover	0.03	1.33	1.33	28.63	1.18
Receivable days	395.14	58.73	36.37	14.18	92.18
Inventory Days	532.68	78.08	105.61	0.00	90.99
Payable days	136.65	12.93	44.03	7.22	100.44
Cash Conversion Cycle	791.18	123.89	97.95	6.96	82.73

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.